Nalaganje...
Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use
Irritable bowel syndrome (IBS) is the most common functional bowel disease that affects up to 15% of the US population. The majority of patients with IBS have significant bloating and gas. Recent evidence is beginning to suggest that patients with IBS may have an alteration in the gastrointestinal f...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3610260/ https://ncbi.nlm.nih.gov/pubmed/23556126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622312472008 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|